Position in SNY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$14,340,921
-$8,195,703 QoQ
Shares Held
336,168
-28.1% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 71%
Shared 1%
None 28%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $24,361,895,957 across 16 Drug Manufacturers - General names. SNY ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,783,459 | $5,737,424,695 | |
| 2 | JNJ |
Johnson & Johnson
|
21,683,347 | $5,506,919,623 | |
| 3 | ABBV |
AbbVie Inc.
|
12,853,368 | $3,234,421,512 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,340,173 | $2,356,712,224 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,263,929 | $1,928,444,775 | |
| 6 | PFE |
Pfizer Inc
|
57,879,546 | $1,393,739,453 | |
| 7 | AMGN |
Amgen Inc
|
3,695,586 | $1,338,245,590 | |
| 8 | AZN |
Astrazeneca PLC
|
6,753,962 | $1,280,686,266 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,340,921 | 336,168 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $22,536,624 | 467,759 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $21,030,181 | 433,970 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $20,957,458 | 444,014 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $23,799,529 | 492,642 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $107,882,062 | 1,945,223 | Shares | Other | 2025-04-29 | |
| 2024-12-31 | $134,335,784 | 2,785,316 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $536,683,748 | 9,312,576 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $417,016,779 | 8,594,740 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $351,111,083 | 7,224,508 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $308,496,616 | 6,203,431 | Shares | Other | 2024-01-29 | |
| 2023-09-30 | $303,095,549 | 5,650,551 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $407,283,543 | 7,556,281 | Shares | Other | 2023-08-03 | |
| 2023-03-31 | $341,427,319 | 6,273,931 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $271,534,217 | 5,606,736 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $119,789,837 | 3,150,706 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $135,782,816 | 2,714,028 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $22,622,763 | 440,646 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $16,813,558 | 335,600 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $15,985,612 | 331,583 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $15,172,238 | 288,117 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $13,581,613 | 274,598 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $15,042,246 | 309,575 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $15,568,751 | 310,320 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $15,641,308 | 306,392 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $18,883,452 | 431,918 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||